Skip to main content

ISIS Pharmaceuticals Inc (NASDAQ: ISIS) Investor Securities Class Action Lawsuit 12/28/2012

  • If you purchased shares of Isis Pharmaceuticals Inc (NASDAQ: ISIS), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 4, 2013 - The case was voluntarily dismissed. December 28, 2012 - An investor in shares of Isis Pharmaceuticals Inc (NASDAQ: ISIS) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Isis Pharmaceuticals Inc in connection certain allegedly false and misleading statements. According to the com...



You must register (for free) or login to view the entire case.